Nomura Holdings
SNOA icon

Nomura Holdings’s Sonoma Pharmaceuticals SNOA Stock Holding History

Nomura Holdings’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-26
Closed -$31K – 2063
2015
Q3 		$31K Buy
26
+3
+13% +$3.56K ﹤0.01% 1571
2015
Q2 		$29K Buy
+23
New +$21.5K ﹤0.01% 1728

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Holdings's SNOA Position: Q4 2015 in Review

Nomura Holdings sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2015, closing a stake of 26 shares — an estimated $31K sold.

Nomura Holdings first reported a position in SNOA in Q2 2015 and held it in 2 quarters. The position peaked at $31K in Q3 2015. 21 funds tracked by Wall St. Rank hold SNOA as of Q4 2015.

  • Nomura Holdings reported no remaining Sonoma Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Nomura Holdings sold 26 Sonoma Pharmaceuticals shares in Q4 2015, an estimated $31K.
  • Nomura Holdings first reported a position in Sonoma Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Nomura Holdings's Sonoma Pharmaceuticals position peaked at $31K in Q3 2015.
  • 21 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2015.

Based on Nomura Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.